Simpson Curran 4
4 · REGENXBIO Inc. · Filed Oct 1, 2025
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
Simpson Curran
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-09-29$10.03/sh−7,624$76,469→ 236,973 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $10.00 to $10.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.